Important ethical issues for nanomedicine.
作者信息
Yasri Sora, Wiwanitkit Viroj
机构信息
KMT Primary Care Center, Bangkok, Thailand.
Department of Tropical Medicine, Hainan Medical University, Hainan Sheng, China.
出版信息
J Res Med Sci. 2017 Dec 26;22:138. doi: 10.4103/jrms.JRMS_856_17. eCollection 2017.
Abstract
摘要
相似文献
1
Important ethical issues for nanomedicine.
J Res Med Sci. 2017 Dec 26;22:138. doi: 10.4103/jrms.JRMS_856_17. eCollection 2017.
2
Scientists' perception of ethical issues in nanomedicine: a case study.
Nanomedicine (Lond). 2011 Jun;6(4):681-91. doi: 10.2217/nnm.11.9. Epub 2011 Apr 20.
3
Upstream ethics in nanomedicine: a call for research.
Nanomedicine (Lond). 2007 Aug;2(4):511-21. doi: 10.2217/17435889.2.4.511.
4
Ethical issues in nanomedicine: Tempest in a teapot?
Med Health Care Philos. 2017 Mar;20(1):3-11. doi: 10.1007/s11019-016-9720-7.
5
Ethical issues in clinical trials involving nanomedicine.
Contemp Clin Trials. 2007 Jul;28(4):433-41. doi: 10.1016/j.cct.2006.11.001. Epub 2006 Nov 17.
6
Nanomedicine-emerging or re-emerging ethical issues? A discussion of four ethical themes.
Med Health Care Philos. 2007 Jun;10(2):173-84. doi: 10.1007/s11019-006-9014-6. Epub 2006 Aug 30.
7
Nanomedicine and ethics: is there anything new or unique?
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):111-118. doi: 10.1002/wnan.90. Epub 2010 Apr 20.
8
Regenerative nanomedicine: ethical, legal, and social issues.
Methods Mol Biol. 2012;811:303-16. doi: 10.1007/978-1-61779-388-2_19.
9
Nanomedicine: ethical concerns beyond diagnostics, drugs, and techniques.
Am J Bioeth. 2009 Oct;9(10):14-5. doi: 10.1080/15265160903013803.
10
A portrait of nanomedicine and its bioethical implications.
J Law Med Ethics. 2012 Winter;40(4):763-79. doi: 10.1111/j.1748-720X.2012.00705.x.
引用本文的文献
1
Advancing glioblastoma therapy with surface-modified nanoparticles.
Neurol Sci. 2025 Sep 13. doi: 10.1007/s10072-025-08457-4.
2
Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology.
Pharmaceuticals (Basel). 2024 May 24;17(6):677. doi: 10.3390/ph17060677.
3
Ethical and legal challenges in nanomedical innovations: a scoping review.
Front Genet. 2023 May 12;14:1163392. doi: 10.3389/fgene.2023.1163392. eCollection 2023.
本文引用的文献
1
Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine.
Curr Oncol. 2016 Dec;23(6):e530-e537. doi: 10.3747/co.23.3214. Epub 2016 Dec 21.
2
Patents in Nanobiotechnology: A Cross Jurisdictional Approach.
Recent Pat Biotechnol. 2017;11(1):52-70. doi: 10.2174/1872208310666161123100223.
3
Ethical issues in nanomedicine: Tempest in a teapot?
Med Health Care Philos. 2017 Mar;20(1):3-11. doi: 10.1007/s11019-016-9720-7.
4
Nanomedicine first-in-human research: challenges for informed consent.
J Law Med Ethics. 2012 Winter;40(4):823-30. doi: 10.1111/j.1748-720X.2012.00710.x.
Zotero 插件